@article{study2023-955fa2a8,
  title   = {{Interim Phase 1 multiple ascending dose results for remternetug (LY3372993) in Alzheimer's disease}},
  journal = {Presented at AD/PD 2023 Conference (Gothenburg, Sweden); covered by ALZFORUM and NeurologyLive},
  year    = {2023}
}